BMS-708163
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BMS-708163, covering 2011-01-25 to 2015-10-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]